Theravance Biopharma Inc (TBPH)
SBC to Revenue
28.89%
Quarterly · Period ending:
TBPH SBC to Revenue
Latest reported28.89%period ending
Latest reported28.89%period ending
TBPH Quarterly SBC/Revenue (0.00% → 28.89%)
Latest values, visible window
High-resolution chart · PNG
TBPH sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 28.8939% | |
| 25.4478% | |
| 9.7623% | |
| 22.8914% | |
| 17.343% | |
| 31.6935% | |
| 31.0654% | |
| 29.4226% | |
| 37.7034% | |
| 36.0546% | |
| 33.1568% | |
| 39.9031% | |
| 45.5597% | |
| 67.3994% | |
| 47.4435% | |
| 68.5086% | |
| 87.8643% | |
| 110.2228% | |
| 113.1942% | |
| 108.9131% | |
| 115.6961% | |
| 111.0472% | |
| 0% | |
| 85.2495% | |
| 0% | |
| 76.9107% | |
| 81.0604% | |
| 104.7638% | |
| 43.2084% | |
| 228.9247% | |
| 74.436% | |
| 91.494% | |
| 59.0177% | |
| 168.2654% | |
| 394.0864% | |
| 249.9415% | |
| 296.3237% | |
| 332.6531% | |
| 176.3879% | |
| 51.8742% | |
| 181.0272% | |
| 61.5426% | |
| 295.6846% | |
| 114.5074% | |
| 205.5369% | |
| 76.5943% | |
| 1,006.2805% | |
| 147.5694% | |
| 227.4042% | |
| 1,344.0212% | |
| 2,948% | |
| 23,308.3333% | |
| 124,140% | |
| 25,072.7273% | |
| 115.5273% | |
| 0% |